KLBF — Net profit grew 18.4% yoy

KLBF — Net profit grew 18.4% yoy Kalbe Farma (KLBF) reported an 18.4% yoy increase in net profit, reaching IDR1.8 tn in 1H24. This growth was driven by robust results across all business segments and effective cost management. The pharma sector, in particular, played a key role in KLBF’s expansion. KLBF has also enhanced its domestic production capabilities, including a facility for surgical sutures, and is advancing toward local assembly of medical equipment to boost its manufacturing potential. Additionally, KLBF is exploring opportunities in healthcare consumables and medical devices, in line with the government's push for higher domestic content in health products. (Source : Bisnis Indonesia)